Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | HTR2B | P41595 | 3/20 | 0.44 |
| ▸ | HTR7 | P34969 | 2/20 | 0.44 |
| ▸ | PNMT | P11086 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 2/20 | 0.36 |
| ▸ | DRD2 | P14416 | 2/20 | 0.36 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8840922 | 0.87 | RAB9A (0.54) | RAB9ANPC1HTR2BHTR7PNMT | |
| SCHEMBL20917777 | 0.85 | RAB9A (0.49) | RAB9ANPC1HTR2BHTR7PNMT | |
| SCHEMBL30616301 | 0.85 | RAB9A (0.49) | RAB9ANPC1HTR2BHTR7PNMT | |
| SCHEMBL30643818 | 0.84 | HTR2B (0.51) | RAB9ANPC1HTR2BHTR7PNMT | |
| SCHEMBL4675573 | 0.84 | HTR2B (0.51) | RAB9ANPC1HTR2BHTR7PNMT | |
| SCHEMBL2131214 | 0.84 | RAB9A (0.55) | RAB9ANPC1HTR2BHTR7PNMT | |
| SCHEMBL30695173 | 0.83 | RAB9A (0.47) | RAB9ANPC1HTR2BHTR7PNMT | |
| SCHEMBL20886929 | 0.81 | TOP1 (0.51) | RAB9ANPC1HTR2BHTR7PNMT | |
| SCHEMBL29112976 | 0.81 | RAB9A (0.46) | RAB9ANPC1HTR2BHTR7PNMT | |
| SCHEMBL2552485 | 0.80 | RAB9A (0.51) | RAB9ANPC1HTR2BHTR7PNMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113292456-B | Preparation method of N-fluorenylmethoxycarbonyl-L-aspartic acid-4-tert-butyl ester | 常州吉恩药业有限公司 | 2022-04-29 | — | — | CN | claimed |
| CN-113292456-A | Preparation method of N-fluorenylmethoxycarbonyl-L-aspartic acid-4-tert-butyl ester | 常州吉恩药业有限公司 | 2021-08-24 | — | — | CN | claimed |
| WO-2014031204-A2 | CARBOHYDRATE-SELECTIVE RECEPTORS | NEW YORK UNIVERSITY (US) | 2014-02-27 | — | — | WO | claimed |
| CN-116375706-B | Abamectin sodium key intermediate and preparation method thereof | 时森海(杭州)医药科技有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-116375706-A | Abamectin sodium key intermediate and preparation method thereof | 时森海(杭州)医药科技有限公司 | 2023-07-04 | — | — | CN | disclosed |
| CN-113292456-B | Preparation method of N-fluorenylmethoxycarbonyl-L-aspartic acid-4-tert-butyl ester | 常州吉恩药业有限公司 | 2022-04-29 | — | — | CN | disclosed |
| CN-113292456-A | Preparation method of N-fluorenylmethoxycarbonyl-L-aspartic acid-4-tert-butyl ester | 常州吉恩药业有限公司 | 2021-08-24 | — | — | CN | disclosed |
| US-9428497-B2 | Precursor compounds for the radiosynthesis of [18F] norchloro-fluorohomoepibatidine | ABX ADVANCED BIOCHEMICAL COMPOUNDS GMBH (DE) | 2016-08-30 | — | — | US | disclosed |
| US-9296688-B2 | Carbohydrate-selective receptors | NEW YORK UNIVERSITY (US) | 2016-03-29 | — | — | US | disclosed |
| US-20150259338-A1 | PRECURSOR COMPOUNDS FOR THE RADIOSYNTHESIS OF [18F] NORCHLORO-FLUOROHOMOEPIBATIDINE | ABX ADVANCED BIOCHEMICAL COMPOUNDS GMBH (GE) | 2015-09-17 | — | — | US | disclosed |
| US-20150141480-A1 | CARBOHYDRATE-SELECTIVE RECEPTORS | NEW YORK UNIVERSITY (US) | 2015-05-21 | — | — | US | disclosed |
| EP-2739622-A1 | PRECURSOR COMPOUNDS FOR THE RADIOSYNTHESIS OF [18F]NORCHLORO-FLUOROHOMOEPIBATIDINE | ABX Advanced Biochemical Compounds GmbH (DE) | 2014-06-11 | — | — | EP | disclosed |
| WO-2014031204-A2 | CARBOHYDRATE-SELECTIVE RECEPTORS | NEW YORK UNIVERSITY (US) | 2014-02-27 | — | — | WO | disclosed |
| WO-2013017585-A1 | PRECURSOR COMPOUNDS FOR THE RADIOSYNTHESIS OF [18F] NORCHLORO-FLUOROHOMOEPIBATIDINE | ABX ADVANCED BIOCHEMICAL COMPOUNDS GMBH (DE) | 2013-02-07 | — | — | WO | disclosed |
| US-5780307-A | IMMUNOPHILIN THAT SPECIFICALLY BINDS FK-506, RAPAMYCIN AND-OR CYCLOSPORIN | SOLDIN STEVEN J (US) | 1998-07-14 | — | — | US | disclosed |
| US-5698448-A | Immunosuppressive drug binding proteins and use | CHILDREN'S RESEARCH INSTITUTE | 1997-12-16 | — | — | US | disclosed |
| EP-0641354-A4 | OLIGONUCLEOTIDES HAVING AMINOHYDROCARBON PHOSPHONATE MOIETIES. | PHARMAGENICS INC (US) | 1996-01-10 | — | — | EP | disclosed |
| WO-1995031572-A1 | AMINOHYDROCARBON PHOSPHONATE OLIGONUCLEOTIDES AND USES THEREFOR | PHARMGENICS, INC. (US) | 1995-11-23 | — | — | WO | disclosed |
| EP-0641354-A1 | OLIGONUCLEOTIDES HAVING AMINOHYDROCARBON PHOSPHONATE MOIETIES | PHARMAGENICS, INC. (US) | 1995-03-08 | — | — | EP | disclosed |
| WO-1993011148-A1 | OLIGONUCLEOTIDES HAVING AMINOHYDROCARBON PHOSPHONATE MOIETIES | PHARMAGENICS, INC. (US) | 1993-06-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150259338-A1 | PRECURSOR COMPOUNDS FOR THE RADIOSYNTHESIS OF [18F] NORCHLORO-FLUOROHOMOEPIBATIDINE | CBR3, CBR1, IDH1 | RAB9A 1105/4885NPC1 523/4885HTR2B 1492/4885 |
| US-20150141480-A1 | CARBOHYDRATE-SELECTIVE RECEPTORS | GPR119, GCGR, GALR1 | RAB9A 1799/4885NPC1 489/4885HTR2B 1005/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.